Literature DB >> 11411652

Urinary tract infection in children associated with idiopathic hypercalciuria.

P Vachvanichsanong1, M Malagon, E S Moore.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the association of symptomatic non-calculous idiopathic hypercalciuria (IH) with urinary tract infection (UTI) in children.
MATERIAL AND METHODS: This was a retrospective case review of children who had urinary calcium excretion greater than 2 mg/kg/day or random urine calcium-creatinine ratio (UCa/UCr) greater than 0.18 mg/mg.
RESULTS: One hundred and twenty-four consecutive children with clinical complaints and elevated urine calcium excretion were reviewed. Fifty children (40%) had UTI of which 39 (78%) had recurrent UTI. There was no difference in age between children with UTI and those without UTI. Twenty-four-hour urine calcium and random UCa/UCr were also not different. Only 4 children (8%) had renal stones whereas hematuria, abdominal pain and urine incontinence were frequent associated findings. Six of the children with recurrent UTI (15%) had an anatomical urinary tract abnormality. Therapy in all children consisted of increased fluid intake and reduction in diet sodium and oxalate; however, 14 of the 39 children with recurrent UTI (36%) required therapy with a thiazide diuretic. Recurrent UTI was abolished in 24 children, one child had a single recurrence and 4 children had no response to treatment.
CONCLUSIONS: We propose that non-calculous IH may be an important contributing factor to recurrent UTI in children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411652     DOI: 10.1080/003655901750170461

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  11 in total

1.  Urinary calcium and uric acid excretion in children with vesicoureteral reflux.

Authors:  Abbas Madani; Nooshin Kermani; Neamatollah Ataei; Seyed Taher Esfahani; Niloufar Hajizadeh; Zahra Khazaeipour; Sima Rafiei
Journal:  Pediatr Nephrol       Date:  2011-08-04       Impact factor: 3.714

Review 2.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

3.  Hypercalciuria and recurrent urinary tract infections: incidence and symptoms in children over 5 years of age.

Authors:  Nese Karaaslan Biyikli; Harika Alpay; Tulay Guran
Journal:  Pediatr Nephrol       Date:  2005-07-27       Impact factor: 3.714

4.  Evaluation of histologic changes in the urinary tract of hypercalciuric rats.

Authors:  Ipek Akil; Salih Kavukçu; Sevinç Inan; Osman Yilmaz; Pergin Atilla; Hüray Işlekel; Nalan Neşe; Sevda Müftüoğlu
Journal:  Pediatr Nephrol       Date:  2006-08-22       Impact factor: 3.714

5.  Recurrent urinary tract infections in an infant with antenatal Bartter syndrome.

Authors:  Velibor Tasic; Liljana Pota; Zoran Gucev
Journal:  World J Pediatr       Date:  2010-02-01       Impact factor: 2.764

6.  Low bone density in children with hypercalciuria and/or nephrolithiasis.

Authors:  Andrew L Schwaderer; Robert Cronin; John D Mahan; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

Review 7.  [Prevention and alternative methods for prophylaxis of recurrent urinary tract infections in women].

Authors:  W Vahlensieck; H Bauer
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

Review 8.  Pharmacological interventions for preventing complications in idiopathic hypercalciuria.

Authors:  Joaquin Escribano; Albert Balaguer; Filomena Pagone; Albert Feliu; Marta Roqué I Figuls
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

9.  Idiopathic hypercalciuria associated with urinary tract infection in children.

Authors:  Vesna D Stojanović; Biljana O Milosević; Milesa B Djapić; Jelena D Bubalo
Journal:  Pediatr Nephrol       Date:  2007-06-01       Impact factor: 3.714

Review 10.  Molecular mechanisms altering tubular calcium reabsorption.

Authors:  Mallory L Downie; R Todd Alexander
Journal:  Pediatr Nephrol       Date:  2021-04-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.